|  | N | OR (95%CI) |  | N | OR (95%CI) |  | N | OR (95%CI) |
---|---|---|---|---|---|---|---|---|---|
Rs599839 | ApoB ≥75th perc | 617 | 2.27 | Tot-chol ≥75th perc | 611 | 1.72 | LDL-chol ≥75th perc | 1304 | 1.63 |
(1.86-2.77) | (1.40-2.10) | (1.32-2.01) | |||||||
 | AG + GG vs AA | 601 | 1.34 | AG + GG vs AA | 562 | 1.13 | AG + GG vs AA | 188 | 1.13 |
(1.10-1.64) | Â | (0.93-1.37) | (0.94-1.37) | ||||||
 | Both | 234 | 1.76 | Both | 474 | 1.80 | Both | 474 | 1.68 |
(1.33-2.34) | (1.36-2.37) | (1.24-2.27) | |||||||
S (95%CI) | Â | Â | 0.47 | Â | Â | 0.94 | Â | Â | 0.89 |
(0.24-0.90) | (0.46-1.92) | (0.38-2.06) | |||||||
Rs646776 | ApoB ≥75th perc | 536 | 2.18 | Tot-chol ≥75th perc | 582 | 1.79 | LDL-chol ≥75th perc | 416 | 1.54 |
(1.76-2.70) | (1.45-2.20) | (1.23-1.93) | |||||||
 | CC + CT vs TT | 787 | 1.09 | CC + CT vs TT | 751 | 0.98 | CC + CT vs TT | 837 | 0.94 |
(0.90-1.33) | (0.81-1.19) | (0.79-1.13) | |||||||
 | Both | 312 | 1.79 | Both | 350 | 1.76 | Both | 243 | 1.68 |
(1.38-2.32) | (1.37-2.25) | (1.27-2.23) | |||||||
S (95%CI) | Â | Â | 0.62 | Â | Â | 0.97 | Â | Â | 1.39 |
 |  |  | (0.34-1.12) |  |  | (0.50-1.89) |  |  | (0.53-3.63) |